Difference between revisions of "Hypericum-fluvoxamine"

From Psychiatrienet
Jump to: navigation, search
Line 9: Line 9:
 
* If necessary, increase dosage of fluvoxamine.
 
* If necessary, increase dosage of fluvoxamine.
 
| info =  
 
| info =  
* Occurence of the serotonin syndrome is theoretically possible so caution is necessary. }}
+
* Occurrence of the serotonin syndrome is theoretically possible so caution is necessary. }}

Revision as of 14:32, 7 May 2009

Hypericum
Type Antidepressant
Group other
links
EMEA 10130408en
PubMed Hypericum
Kompas (Dutch) hypericum extract
Wikipedia St John's wort
Fluvoxamine
Type Antidepressant
Group SSRI
links
Medscape Fluvoxamine
PubChem 5324346
PubMed Fluvoxamine
Kompas (Dutch) Fluvoxamine
Wikipedia Fluvoxamine

Switch medication from hypericum to fluvoxamine.[1] [2]

Nietinrijdenbord.png Stop hypericum
  • Administration of hypericum can be stopped abruptly.
Eenrichtingbord.png Start fluvoxamine
  • Day 1-7: a wash-out period of one week is necessary.
  • Day 8: start administration of fluvoxamine in a dosage of 50 mg/day.
  • If necessary, increase dosage of fluvoxamine.
Infobord.png More information
  • Occurrence of the serotonin syndrome is theoretically possible so caution is necessary.
  1. Switches are based on literature references on this page and expert opinions of the authors. The authors have used pharmacokinetic and receptor affinity properties to determine the switch schedules
  2. Stahl, S. M. (2013). Stahl's essential psychopharmacology: Neuroscientific basis and practical applications (4th ed.). Cambridge University Press.
The editors of psychiatrienet.nl take the greatest care to provide up-to-date and accurate information on this site. Nevertheless, mistakes and omissions cannot be entirely excluded. No rights devolve from the information provided. The editors and other providers of information to this site accept no responsibility for the content of this site or for the information provided therein; neither do they accept responsibility for possible damages which may derive from the use of the information on this site or from the linked sites. The editorial board accepts no responsibility for the content of the (linked) sites, for access to them, or for the products and services on these sites, nor for the occurrence of errors, viruses, and/or disruptions in service.